consider the following job description and candidate profile.
does the candidate profile fulfill the requirements in the job description? format your answer as JSON:
"answer": Yes/No
"reason": explain why in less than 50 words.

Job description:
Recruiting
Client: Avego Healthcare Capital - Private Growth
Restrictions / specific compliance considerations: N/A
Recruiting N/ Total project N: 2/2
Timeline: This week
Suggested Lead Outreach N by Date: 10/13
RMs availability to sync in-person: NAME_1 - anytime
Companies to target: n/a
Region(s)/geo(s): US
Titles or Roles: MD

Intake
Hello - we'd like to speak with oncologists with treat patients with DLBCL. Screening questions below.

• How many refractory or relapsed DLBCL patients do you treat?
• Rate your familiarity with XPOVIO (selinexor) data in DLBCL (SADAL study)
• How many Rx for XPOVIO (selinexor) in DLBCL have you written since its approval in June 2020?
• Over the next year, what % of your 3L and 4L+ patients do you anticipate writing XPOVIO (selinexor)?
• For 3L and 4L+ patients, what % will you write POLIVY (polatuzumab vedotin-piiq), XPOVIO (selinexor) or other therapies? [three %s]

Candidate profile:
NAME_2 is currently employed at ASL Novara - Borgomanero Hospital - Italy, since March 2015, holding the title of Medical Doctor Immunohematology and Transfusion Medicine. Previously, NAME_3 held the position of Field Medical Advisor- Department of medical Affairs, while working at Novartis AG. NAME_3 held this role for 21 months (May 2013 - February 2015). Before this, NAME_3 held the position of Medical Doctor Immunohematology and Transfusion Medicine, while working at Azienda Ospedaliera Ospedale NAME_4 Circolo NAME_4 Busto Arsizio. NAME_3 occupied this position for 19 months (October 2011 - May 2013). Previously, NAME_3 held the position of General Pratictioner, while working at Azienda Sanitaria Locale Varese. NAME_3 held this role for 4 years (March 2007 - August 2011). NAME_3 completed a Second level Master "Clinical management of Thalassemia and Hemoglobinopathies" in Hematology Program from the University of Turin- Italy- Faculty of Medicine, in 2013. Additionally, NAME_3 received a Doctor of Medicine (M.D.), in 2006, from the University of Insubria - Varese - Italy Faculty of Medicine.

NAME_3 has listed the following key skills: Ematologia, GCP, Oncology, Rheumatology, Buona pratica clinica, Hospitals, Internal Medicine, Biotecnologia, Industria farmaceutica, Medical Education, Reumatologia, Clinical Research, Farmacovigilanza, Pharmacovigi